Tough versus soft regulations to promote generic medications in Italy
This paper investigates the effects of regulations aiming to optimise the multi-agency relationships, with a focus on the prescription choice between generic versus branded medications. In 2012, Italian legislators introduced two laws targeting general practitioners prescription behaviour, a soft (recommendations) law followed by a hard (mandatory) law to promote generic medication. We implement a regression discontinuity in time framework and an event study to quarterly administrative data for individuals with chronic kidney disease linked to data from their general practitioners in Emilia-Romagna, Italy. The results indicate that the policies were effective, but had modest effects on increasing the prescription of generic medications. Hard laws seem to have played a key role in driving this change. Heterogeneity checks provide evidence that less competition among GPs and interaction with specialists increased generic medication prescriptions.
Authors
- Gianluca Fiorentini (ORCID: https://orcid.org/0000-0003-4197-9924)
- Naomi Moy (ORCID: https://orcid.org/0000-0003-0413-9053)
- Ayman Fouda (ORCID: https://orcid.org/0000-0002-7511-3662)
- Aarushi Dhingra
Institutions
- Princess Alexandra Hospital (AU)
- Management Center Innsbruck (AT)
- University of Bologna (IT)
Publication Details
- Journal
- The European Journal of Health Economics
- Published
- 2025-09-02
- DOI
- https://doi.org/10.1007/s10198-025-01826-y
- Primary Topic
- Pharmaceutical Economics and Policy
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- LOEWE Zentrum AdRIA
- Università di Bologna